News & Media

gordons

A personal investigation into the lifelong implications of his type 1 diabetes culminated in a $7 million gift from Mike Gordon, co-founder of Meritech Capital Partners, and his wife, Loren, to help...

sagar

When mice with atopic dermatitis—a common type of allergic skin inflammation—are treated with drugs that target the immune system, their thickened, itchy skin generally heals quickly. Sagar Bapat, MD...

mark

The Diabetes Center is pleased to announce the appointment of Mark Anderson, MD, PhD as Director, after serving in an interim capacity since December 2020. Dr. Anderson joined the UCSF faculty in 2003...

Thelin

Martin Thelin, MD PhD a clinical fellow in the Anderson Lab, has been awarded a JDRF Advanced Postdoctoral Fellowship in “Gaining insight into type 1 diabetes pathogenesis through STAT gain of...

Ronin

Emilie Ronin PhD, a postdoctoral fellow in the Tang lab, has been awarded a JDRF Advanced Postdoctoral Fellowship in "Engineering regulatory T cells for type 1 diabetes immunotherapy." The fellowship...

DC21

This year's UCSF Diabetes Academy, hosted by UCSF Foundation, met virtually on October 6, 2021, uniting clinicians and scientists from across UCSF campuses to share the latest advances in diabetes...

New technologies in the effort to discover a cure for type 1 diabetes include figuring out how to rewire the immune system by transplanting islets from donors.

Featuring speakers Julie Sneddon, UCSF, and Everett Meyer, Stanford; a special thanks goes out to Michelle Griffin and Karen Jordan.

This Center is a cure accelerator and a high impact partnership combining the scientific expertise of Stanford University and the University of California, San Francisco (UCSF) within the...

Stephen Gitelman MD, moderates panel discussion with Sarah Kim MD, Audrey Parent PhD, and Shylaja Srinivasan MD